References and Supporting Research

National Headache Foundation
5252 North Western Avenue
Chicago, IL  60625

American Council for Headache Education (ACHE)
875 Kings Highway Suite 200
Woodbury, NJ  08096

  1. Aloisi, P., Marrelli, A., Porto, C., Tozzi, E., Cerone, G. Visual evoked potentials and serum magnesium levels in juvenile migraine patients. Headache 1997 Jun; 37(6): 383-5.
  2. Blok, WL, Kata, MB, van der Meer J. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996;126:1515-33.
  3. Bucci, LR. Nutrition Applied to Injury Rehabilitation and Sports Medicine. Boca Ranton, FL: CRC Press; 1995.
  4. Claustrat, B., Brun, J., Geoffriau, M., Zaidan, R., Mallo, C., Chazot, G. Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia 1997 Jun; 17(4): 511-7; discussion, 487.
  5. Erasmus, U. Fats That Heal, Fats That Kill 2nd ed. Burnaby BC, Canada: Alive Books; 1993.
  6. Feig, C. Dentist Advocates Cold Gel for Migraines 2002. CNN Medical Unit/ Health (
  7. Grossman, W., Schmidramsl, H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Altern. Med. Rev. 2001 Jun; 6(3): 303-10.
  8. James, MJ, Gibson, RA, Clealand, LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71(Suppl):343S-48S.
  9. Kremer, JM, Lawrence, DA, Petrillo, GF, et al. Effects of high dose fish oil on rheumatoid arthritis after stopping nonsteroi­dal anti-inflammatory drugs. Arth Rheum 1995;38(8):1107-14.
  10. Kunkel, SL, Ogawa, H, Ward, PA, et al. Suppression of chronic inflammation by evening primrose oil. Prog Lipid Res 1982;20:885-88.
  11. Lauritzen, C. Results of a 5 year prospective study of estriol succinate treatment in patients with climacteric complaints. Horm. Metab. Res. 1987 Nov; 19(11): 579-84.
  12. Mauskop, A., Altura, B.M. Role of magnesium in the pathogenesis and treatment of migraines. Clin. Neurosci. 1998; 5(1): 24-7.
  13. Meydani, SN. Effect of (n-3) polyunsaturated fatty acids on cytokine production and their biologic function. Nutr 1996;12:S8-S14.
  14. Murphy, J.J., Heptinstall, S., Mitchell, J.R. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988 Jul 23; 2(8604): 189-92.
  15. Palevitch, D., Earon, G., Carasso, R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytother. Res. 1997; 11(7): 508-11.
  16. Pedley, Timothy, MD, chairman, Department of Neurology, Columbia University, New York.
  17. Pullman-Mooar, Lapsosta, M, Lem, D, et al. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arth Rheum 1990;33(10):1526-33.
  18. Rosen, T.D. Coenzyme Q10 may stave off migraine. Cephalalgia 2002 Mar; 22: 137-41; see instead Rozen, T.D., Oshinsky, M.L., Gebeline, C.A., Bradley, K.C., Young, W.B., Shechter, A.L., Silberstein, S.D. Open label trial of coenzyme Q10 as a migraine preventative. Cephalalgia 2002 Mar; 22(2): 137-41.
  19. Russell, A.L., McCarty, M.F. Glucosamine for migraine prophylaxis? Med. Hypotheses 2000 Sep; 55(3): 195-8.
  20. Sandor, P.S., Afra, J., Ambrosini, A., Schoenen, J. Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 2000 Jan; 40(1): 30-5.
  21. Schoenen, J., Lenaerts, M., Bastings, E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994; 14(5): 328-9.
  22. Silberstein, Stephen, MD, director, Thomas Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia.
  23. Simopoulos, AP. Omega-3 ftty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438-63.
  24. Warner, Jennifer. “Taking the Pain Out of Migraine Treatments”, WebMD Medical News, Dec.4, 2003.
  25. Welch, K.M. Pathogenesis of migraine. Semin. Neurol. 1997; 17(4): 335-41.

26. Hinz, ML. Migraines. Taken from on May 14, 2009.

27. JAMA. 2004;291:427-434, 493-494.

28. Kurth T, et al. JAMA 2006;296:283-291.

29. Kurth T, et al. Arch Intern Med. 2007;167:795-801.

30. Bousser MG, et al. Cephalalgia. 2000;20:155-156.

31. MacGregor EA, de Lignieres B. Cephalalgia. 2000;20:157-163.

32. Corvaglia L, et al. Depression in adult untreated celiac subjects: diagnosis by the pediatrician. Am J Gastroenterol. 1999 Mar; 94(3):839-43.

33. Ciacci C, et al. Depressive symptoms in adult coeliac disease. Scand J Gastroenterol. 1998 Mar;33(3):247-50.

34. Addolorato G, et al. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality “trait” or a reactive illness? Hepatogastroenterology. 1996 Nov-Dec;43(12):1513-7.

35. Pellegrino M, et al. Untreated coeliac disease and attempted suicide. Lancet. 1995 Sep 30;346(8979):915.

36. Cheliout W. [A misleading depression]. Encephale. 1994 Sep-Oct;20(5):531-4. French.

37. Hernanz A, et al. Plasma precursor amino acids of central nervous system monoamines in children with coeliac disease. Gut. 1991 Dec;32(12):1478-81.

38. van Praag HM. Affective disorders and aggression disorders: evidence for a common biological mechanism. Suicide Life Threat Behav. 1986 Summer;16(2):103-32. Review.

39. Hallert C, et al. Psychic disturbances in adult coeliac disease. I. Clinical observations. Scand J Gastroenterol. 1982 Jan;17(1):17-9.

Contact Us

Call us at 866-888-6721
Email us at

Connect with Us

Our Facebook and Twitter pages are constantly being updated with helpful information on healthy living.